Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy

Molecular Immunology

Volumn 47, Issue 6, 2010, Pages 1292-1298

  Gadermaier, Gabriele ^a   Jahn Schmid, Beatrice ^b   Vogel, Lothar ^c   Egger, Matthias ^a   Himly, Martin ^a   Briza, Peter ^a   Ebner, Christof ^d   Vieths, Stefan ^c   Bohle, Barbara ^b,e   Ferreira, Fatima ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b Institute of Plant Physiology   (Austria)

^c PAUL EHRLICH INSTITUT   (Germany)

^d Allergie Ambulatorium Rennweg Vienna   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Art v 1; Artemisia pollen allergy; Cysteine variants; Defensin; Glycoallergen; Hypoallergen; Site directed mutagenesis; T cell epitope

Indexed keywords

CYSTEINE; IMMUNOGLOBULIN E; POLLEN ANTIGEN;

ALLERGENICITY; ANIMAL CELL; ARTEMISIA; ARTICLE; BASOPHIL; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTHERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL CHEMISTRY; POLLEN ALLERGY; PRIORITY JOURNAL; RAT; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; ANTIBODIES; CELL PROLIFERATION; CONSERVED SEQUENCE; CYSTEINE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MUTANT PROTEINS; PLANT PROTEINS; POLLEN; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RATS; T-LYMPHOCYTES;

ARTEMISIA; ARTEMISIA VULGARIS; RATTUS;

EID: 76949100653     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.11.029     Document Type: Article

References (35)

1. Aalberse R.C., and Stadler B.M. In silico predictability of allergenicity: from amino acid sequence via 3-D structure to allergenicity. Mol. Nutr. Food Res. 50 (2006) 625-627
2. Barth S., Huhn M., Matthey B., Klimka A., Galinski E.A., and Engert A. Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions. Appl. Environ. Microbiol. 66 (2000) 1572-1579
3. Bauer R., Himly M., Dedic A., Ferreira F., Thalhamer J., and Hartl A. Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen. Allergy 58 (2003) 1003-1010
4. Dedic A., Gadermaier G., Vogel L., Ebner C., Vieths S., Ferreira F., and Egger M. Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1. Mol. Immunol. 46 (2009) 416-421
5. Egger M., Mutschlechner S., Wopfner N., Gadermaier G., Briza P., and Ferreira F. Pollen-food syndromes associated with weed pollinosis: an update from the molecular point of view. Allergy 61 (2006) 461-476
6. Ferreira F., Wallner M., Gadermaier G., Erler A., Fritz G., Glatter O., Himly M., Briza P., and van Ree R. Physico-chemical characterization of candidate reference materials. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M (2006) 75-82 (Discussion 82-3, 100-4)
7. Gadermaier G., Wopfner N., Wallner M., Egger M., Didierlaurent A., Regl G., Aberger F., Lang R., Ferreira F., and Hawranek T. Array-based profiling of ragweed and mugwort pollen allergens. Allergy 63 (2008) 1543-1549
8. Gonzalez-Rioja R., Ibarrola I., Arilla M.C., Ferrer A., Mir A., Andreu C., Martinez A., and Asturias J.A. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy. J. Allergy Clin. Immunol. 120 (2007) 602-609
9. Gruber P., Gadermaier G., Bauer R., Weiss R., Wagner S., Leonard R., Breiteneder H., Ebner C., Ferreira F., and Egger M. The role of polypeptide backbone and post-translational modifications on cross-reactivity of Art v 1, the mugwort pollen major allergen. Biol. Chem. (2009)
10. Himly M., Jahn-Schmid B., Dedic A., Kelemen P., Wopfner N., Altmann F., van Ree R., Briza P., Richter K., Ebner C., and Ferreira F. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. FASEB J. 17 (2003) 106-108
11. Himly M., Nony E., Chabre H., Van Overtvelt L., Neubauer A., van Ree R., Buchheit K.H., Vieths S., Moingeon P., and Ferreira F. Standardization of allergen products. 1. Detailed characterization of GMP-produced recombinant Bet v 1. 0101 as biological reference preparation. Allergy (2009)
12. Jahn-Schmid B., Fischer G.F., Bohle B., Fae I., Gadermaier G., Dedic A., Ferreira F., and Ebner C. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J. Allergy Clin. Immunol. 115 (2005) 399-404
13. Jahn-Schmid B., Kelemen P., Himly M., Bohle B., Fischer G., Ferreira F., and Ebner C. The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J. Immunol. 169 (2002) 6005-6011
14. Jahn-Schmid B., Sirven P., Leb V., Pickl W.F., Fischer G.F., Gadermaier G., Egger M., Ebner C., Ferreira F., Maillere B., and Bohle B. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J. Immunol. 181 (2008) 3636-3642
15. Kahlert H., Suck R., Weber B., Nandy A., Wald M., Keller W., Cromwell O., and Fiebig H. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Int. Arch. Allergy Immunol. 145 (2008) 193-206
16. Katial R.K., Lin F.L., Stafford W.W., Ledoux R.A., Westley C.R., and Weber R.W. Mugwort and sage (Artemisia) pollen cross-reactivity: ELISA inhibition and immunoblot evaluation. Ann. Allergy Asthma Immunol. 79 (1997) 340-346
17. Kettner J., Meyer H., Narkus A., Cromwell O., and Jost K. Specific immunotherapy with recombinant birch pollen allergen rBet v 1-FV is clinically efficacious-results of a phase III study. Allergy 62 (2007) 33
18. Kindermans J.M., Pilloy J., Olliaro P., and Gomes M. Ensuring sustained ACT production and reliable artemisinin supply. Malariol. J. 6 (2007) 125
19. Leb V.M., Jahn-Schmid B., Schmetterer K.G., Kueng H.J., Haiderer D., Neunkirchner A., Fischer G.F., Nissler K., Hartl A., Thalhamer J., Bohle B., Seed B., and Pickl W.F. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. J. Allergy Clin. Immunol. 121 (2008) 64-71
20. Leonard R., Petersen B.O., Himly M., Kaar W., Wopfner N., Kolarich D., van Ree R., Ebner C., Duus J.O., Ferreira F., and Altmann F. Two novel types of O-glycans on the mugwort pollen allergen Art v 1 and their role in antibody binding. J. Biol. Chem. 280 (2005) 7932-7940
21. Li J., Sun B., Huang Y., Lin X., Zhao D., Tan G., Wu J., Zhao H., Cao L., and Zhong N. A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy (2009)
22. Li M., Gustchina A., Alexandratos J., Wlodawer A., Wunschmann S., Kepley C.L., Chapman M.D., and Pomes A. Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J. Biol. Chem. (2008)
23. Marazuela E.G., Rodriguez R., Barber D., Villalba M., and Batanero E. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines. Clin. Exp. Allergy 37 (2007) 251-260
24. Montesinos E. Antimicrobial peptides and plant disease control. FEMS Microbiol. Lett. 270 (2007) 1-11
25. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4 (2004) 469-478
26. Sheffield P., Garrard S., and Derewenda Z. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Exp. Purif. 15 (1999) 34-39
27. Silverstein K.A., Moskal Jr. W.A., Wu H.C., Underwood B.A., Graham M.A., Town C.D., and VandenBosch K.A. Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants. Plant J. 51 (2007) 262-280
28. Smith A.M., and Chapman M.D. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol. Immunol. 33 (1996) 399-405
29. Soares M.R., Bisch P.M., Campos de Carvalho A.C., Valente A.P., and Almeida F.C. Correlation between conformation and antibody binding: NMR structure of cross-reactive peptides from T. cruzi, human and L. braziliensis. FEBS Lett. 560 (2004) 134-140
30. Takai T., Yokota T., Yasue M., Nishiyama C., Yuuki T., Mori A., Okudaira H., and Okumura Y. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat. Biotechnol. 15 (1997) 754-758
31. Vaz D.C., Rodrigues J.R., Sebald W., Dobson C.M., and Brito R.M. Enthalpic and entropic contributions mediate the role of disulfide bonds on the conformational stability of interleukin-4. Protein Sci. 15 (2006) 33-44
32. Vogel L., Luttkopf D., Hatahet L., Haustein D., and Vieths S. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 60 (2005) 1021-1028
33. Wallner M., Stocklinger A., Thalhamer T., Bohle B., Vogel L., Briza P., Breiteneder H., Vieths S., Hartl A., Mari A., Ebner C., Lackner P., Hammerl P., Thalhamer J., and Ferreira F. Allergy multivaccines created by DNA shuffling of tree pollen allergens. J. Allergy Clin. Immunol. 120 (2007) 374-380
34. White N.J. Qinghaosu (artemisinin): the price of success. Science 320 (2008) 330-334
35. Wopfner N., Gadermaier G., Egger M., Asero R., Ebner C., Jahn-Schmid B., and Ferreira F. The spectrum of allergens in ragweed and mugwort pollen. Int. Arch. Allergy Immunol. 138 (2005) 337-346